Intraperitoneal injection of SR-8314 and SR-8291 led to increased frequencies of CD4+ and CD8+ T cells and a decrease in tumor-associated macrophages in tumor-bearing mice [97]. The gene discussed is CD8A; the disease is neoplasm.